← Leaderboards
Jianfeng Cai
University Of South Florida
$10,262,045
Attributed
$14,702,175
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.3M · FY2015–25$5M$3.8M$2.5M$1.3M$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,702,175 · 9
By mechanism
R01$10,629,615 · 6
RF1$3,297,926 · 1
R21$411,125 · 1
R56$363,509 · 1
Top collaborators
- Chuanhai Cao7 shared
- Xingmin Sun5 shared
- Yu Chen2 shared
- Prahathees Jai Eswara2 shared
- Donghui Zhu1 shared
Most similar at University Of South Florida
Same institution · by research overlap
- Xiaopeng Li$570,158
- Yongrong Zhang$471,371
- Jianjun Pan$503,879
- Shekhar Bhansali$8,895,380
- Jianfeng Cai$890,000
Others in their field
Top investigators on “Lead”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$423,098,075
- David Heimbrook · Leidos Biomedical Research, Inc.$406,926,511
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$382,410,253
Research focus
LeadDesignPeptidesInnovationBiocompatible MaterialsGenerationsMouse ModelIn VivoFoundationsAntibioticsBaseAlzheimer&AposStructureToxic EffectMembraneResistanceAnalogSeriesBindingModificationAntibiotic ResistancePlayPublishingInfection
Grant awards (33)
Inhibition of Abeta42 aggregation by helix stabilizing peptidomimetic biomaterials$3,297,926
RF1 · FY2025 · AG · contact PI
Recognition of Abeta monomeric helix$568,883
R01 · FY2025 · AG · contact PI
Targeting Wnt signaling pathway$411,589
R01 · FY2025 · GM · contact PI
Recognition of Abeta monomeric helix$580,493
R01 · FY2024 · AG · contact PI
Targeting Wnt signaling pathway$413,625
R01 · FY2024 · GM · contact PI
Antimicrobial agents derived from AApeptide biomaterials$373,750
R01 · FY2024 · AI · contact PI
Recognition of Abeta monomeric helix$579,848
R01 · FY2023 · AG · contact PI
Targeting Wnt signaling pathway$426,216
R01 · FY2023 · GM · contact PI
Novel polymer biomaterials combating C. difficile infection$373,750
R01 · FY2023 · AI · contact PI
Antimicrobial agents derived from AApeptide biomaterials$373,750
R01 · FY2023 · AI · contact PI
Antimicrobial agents derived from AApeptide biomaterials$373,750
R01 · FY2022 · AI · contact PI
Novel polymer biomaterials combating C. difficile infection$373,750
R01 · FY2022 · AI · contact PI
Characterization and Inhibition of protein-protein interactions involving Staphylococcus aureus GpsB$186,875
R21 · FY2022 · AI
Antimicrobial agents derived from AApeptide biomaterials$373,750
R01 · FY2021 · AI · contact PI
Novel polymer biomaterials combating C. difficile infection$373,750
R01 · FY2021 · AI · contact PI
Gamma-AApeptides as novel biomaterials inhibiting Abeta peptide aggregation$355,839
R01 · FY2021 · AG · contact PI
Self-assembly of 2D metallo-supramolecules as a novel class of antimicrobial biomaterials via forming transmembrane channels$282,405
R01 · FY2021 · GM · contact PI
Characterization and Inhibition of protein-protein interactions involving Staphylococcus aureus GpsB$224,250
R21 · FY2021 · AI
Novel polymer biomaterials combating C. difficile infection$373,750
R01 · FY2020 · AI · contact PI
Antimicrobial agents derived from AApeptide biomaterials$373,750
R01 · FY2020 · AI · contact PI
Gamma-AApeptides as novel biomaterials inhibiting Abeta peptide aggregation$358,175
R01 · FY2020 · AG · contact PI
Self-assembly of 2D metallo-supramolecules as a novel class of antimicrobial biomaterials via forming transmembrane channels$283,595
R01 · FY2020 · GM · contact PI
Novel polymer biomaterials combating C. difficile infection$373,750
R01 · FY2019 · AI · contact PI
Gamma-AApeptides as novel biomaterials inhibiting Abeta peptide aggregation$360,207
R01 · FY2019 · AG · contact PI
Alpha-AApeptides as a novel class of antimicrobial biomaterials$291,788
R01 · FY2019 · GM · contact PI
Gamma-AApeptides as novel biomaterials inhibiting Abeta peptide aggregation$361,973
R01 · FY2018 · AG · contact PI
Alpha-AApeptides as a novel class of antimicrobial biomaterials$293,704
R01 · FY2018 · GM · contact PI
Requesting HPLC for the project of "Alpha-AApeptides as a Novel Class of Antimicrobial Biomaterials"$70,000
R01 · FY2018 · GM · contact PI
Gamma-AApeptides as novel biomaterials inhibiting Abeta peptide aggregation$363,509
R01 · FY2017 · AG · contact PI
Alpha-AApeptides as a novel class of antimicrobial biomaterials$295,370
R01 · FY2017 · GM · contact PI
Alpha-AApeptides as a novel class of antimicrobial biomaterials$296,818
R01 · FY2016 · GM · contact PI
Novel non-natural oligomers that mimic the structure and function of bioactive peptides$363,509
R56 · FY2015 · AI · contact PI
Alpha-AApeptides as a novel class of antimicrobial biomaterials$298,078
R01 · FY2015 · GM · contact PI